Research progress on treatment of liver cirrhosis induced by hepatitis C
10.3760/cma.j.issn.1674-2397.2014.01.021
- VernacularTitle:丙型肝炎肝硬化临床治疗的研究进展
- Author:
Xingxing WANG
;
Shuang LI
;
Donghui ZHOU
- Publication Type:Journal Article
- Keywords:
Hepatitis C;
Liver cirrhosis;
Antiviral therapy;
Sustained virological response
- From:
Chinese Journal of Clinical Infectious Diseases
2014;7(1):85-88
- CountryChina
- Language:Chinese
-
Abstract:
Pegylated interferon plus ribavirin is still the standard treatment for hepatitis C,but the efficacy is often restricted by adverse events.HCV genotypes,viral dynamics during early treatment and gene polymorphism may be useful in predicting the efficacy of antiviral treatment.Several strategies have emerged to improve outcomes including low accelerating dose regimen (LADR) and prevention of complications.Direct antiviral drugs have been already used for HCV genotype 1 patients,and demonstrated improved efficacy.Besides,inhibitors and vitamin D may also be applied in antiviral therapy to improve the efficacy.This article reviews efficacy predictors,standard therapy,strategies and research on new medicaments in antiviral treatment of hepatitis C.
